))
Why everyone's talking about biosimilars
Manage episode 502529861 series 3608240
Content provided by Matt McGuire and CVS Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt McGuire and CVS Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Joshua Fredell, SVP, Pharmacy Services, shares insights on this biologic drug and why it matters.
• Our history of innovation at CVS Caremark demonstrates that we are uniquely positioned to positively impact the market.
• Members feel supported when their prescription plan prioritizes affordability, and their biosimilars are backed by regulatory approval for safety and efficacy, Joshua notes.
• "If we remain focused on driving to lower-cost products and using our technology to make that even easier for everyone involved, we will be able to maximize the savings potential that biosimilars provide," Joshua says.
11 episodes
Share
